title: Design checkpoint kinase 2 inhibitors by pharmacophore modeling and virtual screening techniques.
abstract: Damage to DNA is caused by ionizing radiation, genotoxic chemicals or collapsed replication forks. When DNA is damaged or cells fail to respond, a mutation that is associated with breast or ovarian cancer may occur. Mammalian cells control and stabilize the genome using a cell cycle checkpoint to prevent damage to DNA or to repair damaged DNA. Checkpoint kinase 2 (Chk2) is one of the important kinases, which strongly affects DNA-damage and plays an important role in the response to the breakage of DNA double-strands and related lesions. Therefore, this study concerns Chk2. Its purpose is to find potential inhibitors using the pharmacophore hypotheses (PhModels) and virtual screening techniques. PhModels can identify inhibitors with high biological activities and virtual screening techniques are used to screen the database of the National Cancer Institute (NCI) to retrieve compounds that exhibit all of the pharmacophoric features of potential inhibitors with high interaction energy. Ten PhModels were generated using the HypoGen best algorithm. The established PhModel, Hypo01, was evaluated by performing a cost function analysis of its correlation coefficient (r), root mean square deviation (RMSD), cost difference, and configuration cost, with the values 0.955, 1.28, 192.51, and 16.07, respectively. The result of Fischer's cross-validation test for the Hypo01 model yielded a 95% confidence level, and the correlation coefficient of the testing set (rtest) had a best value of 0.81. The potential inhibitors were then chosen from the NCI database by Hypo01 model screening and molecular docking using the cdocker docking program. Finally, the selected compounds exhibited the identified pharmacophoric features and had a high interaction energy between the ligand and the receptor. Eighty-three potential inhibitors for Chk2 are retrieved for further study.
authors.affiliation: Department of Computer Science and Information Engineering, Chang Gung University, Taoyuan 33302, Taiwan.
authors.forename: Yen-Ling
authors.initials: YL
authors.lastname: Wang
authors.forename: Chun-Yuan
authors.initials: CY
authors.lastname: Lin
authors.forename: Kuei-Chung
authors.initials: KC
authors.lastname: Shih
authors.forename: Jui-Wen
authors.initials: JW
authors.lastname: Huang
authors.forename: Chuan-Yi
authors.initials: CY
authors.lastname: Tang
mesh_terms: D064447:Checkpoint Kinase 2 / Q000037:antagonists & inhibitors* / Q000737:chemistry; D004249:DNA Damage; D015195:Drug Design; D006801:Humans; D008958:Models, Molecular; D047428:Protein Kinase Inhibitors / Q000737:chemistry* / Q000494:pharmacology*; D021281:Quantitative Structure-Activity Relationship; D013329:Structure-Activity Relationship; D013816:Thermodynamics
chemical_list: D047428:Protein Kinase Inhibitors; D064447:Checkpoint Kinase 2
keywords: Chk2; Drug design; Pharmacophore; Virtual screening